SY Stock Analysis: Buy, Sell, or Hold?
SY - So-Young International Inc. American Depository Shares
$1.73
-0.05 (-2.81%)
▼
5d:
-6.99%
30d:
-39.3%
90d:
-48.2%
HOLD
LOW Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: May 22, 2026
0d
Get Alerted When SY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: SY is currently trading at $1.73, which is considered oversold relative to its 30-day fair value range of $1.84 to $2.74. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.0) compared to its historical average (5.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SY is in a strong uptrend. The price is currently testing key support at $1.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.33 (+323.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SY is in a strong uptrend. The price is currently testing key support at $1.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.33 (+323.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.84 -
$2.74
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 323.8% below Wall St target ($7.33)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.84 -
$2.74
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.80
Resistance Level
$2.22
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.00
Wall Street Target
$7.33
(+323.8%)
Revenue Growth (YoY)
45.6%
Earnings Growth (YoY)
7.5%
Profit Margin
-15.6%
PE vs Historical
-3.0 vs 5.0
CHEAP
Share & Embed Analysis
Last updated: June 16, 2026 11:46 PM ET
Data refreshes hourly during market hours. Next update: 12:46 AM
Data refreshes hourly during market hours. Next update: 12:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 50 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 64 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 54 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 57 HOLD |
